Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio transformation. Yet, the company’s operations face the wrath of excessive ...

Furthermore, Bruker (NASDAQ:BRKR)'s TwinScape™ has emerged as a cloud-based, AI-enabled proteomics quality monitoring solution, which is now monitoring hundreds of customer systems. It has been ...

CellScape with New Software Engine to Improve Throughput and Data Quality Bruker announces enhancements to its CellScape platform for spatial proteomics with the PowerOMX™ Engine. PowerOMX is ...

The London Company, an investment management company, released “The London Company Large Cap Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S.

Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope ...

Bruker’s differentiated systems and solutions support research in the fields of preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology ...

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...

Furthermore, Bruker (NASDAQ:BRKR)'s TwinScape™ has emerged as a cloud-based, AI-enabled proteomics quality monitoring solution, which is now monitoring hundreds of customer systems. It has been ...

Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell ...

enhanced technology engine to power CellScape™ for spatial proteomics; expansion to 1000-plex protein assay on GeoMx® DSP; and launch of PaintScape™, a revolutionary platform enabling direct ...